μ-Chlorido-bis-{[1-benzyl-3-(2,4,6-tri-methyl-phen-yl)imidazol-2-yl-idene-κ]silver(I)} chloride 1,2-di-chloro-ethane hemisolvate.
ベンジル基およびメシチル基を有するN複素環カルベン銀(I)錯体の結晶構造と抗菌特性
Abstract
A dinuclear silver(I) complex bridged by a chlorido ligand was prepared from an imidazolium chloride precursor bearing benzyl and 2,4,6-trimethylphenyl (mesityl) N-substituents, using sodium bis(trimethylsilyl)amide and silver chloride as reagents. Structural characterization by NMR spectroscopy and single-crystal X-ray diffraction at 110 K revealed monoclinic symmetry (space group 2/m). The crystal packing features multiple weak intermolecular hydrogen-bonding contacts involving the chloride counter-anion. The compound is noted for its potential antibacterial properties.
Bibliographic
- Authors
- Malek K, Arumugam K
- Journal
- IUCrdata
- Year
- 2024
- PMID
- 39371668
- DOI
- 10.1107/S2414314624008617
- PMC
- PMC11451033
No disease / mechanism tags on this paper. Browse evidence summaries by disease at the disease / mechanism index.
Delivery context
The delivery route is not clearly identifiable from this paper. For hydrogen intake, inhalation is the most efficient route; inhalation, however, carries explosion risk (empirical LFL of 10%; high-concentration devices are not recommended).
Safety notes
See also: